3SBio (STU:83B) Other Current Payables: €47 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:83B 3SBio Inc STU:83B
91 GF Score
Price €1.92
GF Value €1.61
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is 3SBio Other Current Payables?

3SBio STU:83B -4.15% 91 Other Current Payables is €47 Mil as of Dec. 2025. GuruFocus rates STU:83B with a GF Score™ of 91/100 and a GF Value™ of €1.61 (Modestly Overvalued). The stock has 1 warning sign investors should review.

3SBio's Other Current Payables for the quarter that ended in Dec. 2025 was €47 Mil.

3SBio's quarterly Other Current Payables increased from Dec. 2024 (€69 Mil) to Jun. 2025 (€106 Mil) but then declined from Jun. 2025 (€106 Mil) to Dec. 2025 (€47 Mil).

3SBio's annual Other Current Payables increased from Dec. 2023 (€40 Mil) to Dec. 2024 (€69 Mil) but then declined from Dec. 2024 (€69 Mil) to Dec. 2025 (€47 Mil).

3SBio Other Current Payables Related Terms

3SBio Other Current Payables Historical Data

* Premium members only.

The historical data trend for 3SBio's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio Other Current Payables Chart

3SBio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.75 31.82 40.48 68.85 47.37

3SBio Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.48 122.47 68.85 106.28 47.37
STU:83B
91GF Score
3SBio Inc STU:83B
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3SBio Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €47 Mil mean?
3SBio (STU:83B) has a Other Current Payables of €47 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on 3SBio and its competitors.
Is 3SBio's Other Current Payables too high?
3SBio's current Other Current Payables is €47 Mil. Overall, 3SBio has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's Other Current Payables compare to VRTX and REGN?
3SBio's Other Current Payables of €47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on 3SBio and its competitors. 3SBio's current Other Current Payables is €47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (STU:83B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.61, compared to a current price of €1.92 — trading 19.4% above its estimated fair value. The current Other Current Payables is €47 Mil. 3SBio's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For 3SBio (STU:83B), the current Other Current Payables is €47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3SBio (STU:83B) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of €1.92 is trading 19.4% above its estimated GF Value™ of €1.61. GuruFocus considers 3SBio to be Modestly Overvalued.

Key valuation signals for STU:83B:

  • Other Current Payables: €47 Mil
  • GF Value™: €1.61 vs. price of €1.92 (19.4% above fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the STU:83B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Other Exchanges TRSBF:USA01530:Hong Kong
Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
91GF Score

Get the complete analysis for STU:83B

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.92
Price
€1.61
GF Value